| RS2075687773 |
SMC1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2075687835 |
SMC1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 85 |
| RS2075701790 |
SMC1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Developmental and epileptic encephalopathy |
| RS2075702300 |
SMC1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 85 |
| RS2075725792 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2075725850 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2075726992 |
SMC1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2075758478 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2075764795 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2075824424 |
HSD17B10
|
Health Risk |
Likely pathogenic |
HSD10 mitochondrial disease, HSD10 mitochondrial disease |
| RS2075831472 |
HERC2
|
Health Risk |
Pathogenic |
— |
| RS2075834227 |
HSD17B10
|
Health Risk |
Likely pathogenic |
HSD10 mitochondrial disease, HSD10 mitochondrial disease |
| RS2075872773 |
CTNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Ocular cystinosis, Juvenile nephropathic cystinosis |
| RS2075900501 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2075906916 |
CTNS
|
Health Risk |
Likely pathogenic |
Juvenile nephropathic cystinosis, Ocular cystinosis |
| RS2075909295 |
CTNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephropathic cystinosis, Ocular cystinosis |
| RS2075920978 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2075964628 |
AR
|
Health Risk |
Conflicting classifications of pathogenicity |
Androgen resistance syndrome, Kennedy disease |
| RS2075964906 |
AR
|
Health Risk |
Pathogenic |
— |
| RS2075975847 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2076013475 |
MBOAT7
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 57 |
| RS2076017638 |
MBOAT7
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 57 |
| RS2076070300 |
BAG5
|
Health Risk |
Pathogenic |
Cardiomyopathy, dilated |
| RS2076073941 |
HERC1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2076078319 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2076092608 |
CTNS
|
Health Risk |
Likely pathogenic |
Juvenile nephropathic cystinosis, Ocular cystinosis |
| RS2076093998 |
AR
|
Health Risk |
Likely pathogenic |
— |
| RS2076094126 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2076094436 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2076094603 |
CTNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephropathic cystinosis, Ocular cystinosis |
| RS2076094679 |
AR
|
Health Risk |
Conflicting classifications of pathogenicity |
Androgen resistance syndrome, Kennedy disease |
| RS2076095044 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2076099474 |
COA8
|
Health Risk |
Pathogenic |
— |
| RS2076100543 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Nephropathic cystinosis |
| RS2076100759 |
CTNS
|
Health Risk |
Likely pathogenic |
Ocular cystinosis, Juvenile nephropathic cystinosis |
| RS2076101632 |
CTNS
|
Health Risk |
Pathogenic |
Juvenile nephropathic cystinosis, Ocular cystinosis |
| RS2076101974 |
CTNS
|
Health Risk |
Pathogenic |
Ocular cystinosis, Juvenile nephropathic cystinosis |
| RS2076113325 |
CD40LG
|
Health Risk |
Likely pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2076118513 |
AR
|
Health Risk |
Likely pathogenic |
— |
| RS2076118553 |
AR
|
Health Risk |
Pathogenic |
Kennedy disease, Androgen resistance syndrome |
| RS2076118841 |
CD40LG
|
Health Risk |
Pathogenic |
Hyperimmunoglobulin M syndrome, Hyperimmunoglobulin M syndrome |
| RS2076118894 |
AR
|
Health Risk |
Conflicting classifications of pathogenicity |
Androgen resistance syndrome, Kennedy disease |
| RS2076118909 |
AR
|
Health Risk |
Likely pathogenic |
— |
| RS2076119092 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2076119100 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2076119189 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2076126859 |
CD40LG
|
Health Risk |
Likely pathogenic |
— |
| RS2076126996 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2076127075 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2076127133 |
CD40LG
|
Health Risk |
Likely pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2076127276 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2076127875 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2076137289 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS2076137339 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2076137708 |
AR
|
Health Risk |
Likely pathogenic |
— |
| RS2076139894 |
IFT122
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS2076142436 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2076142560 |
AR
|
Health Risk |
Conflicting classifications of pathogenicity |
Kennedy disease, Androgen resistance syndrome |
| RS2076147482 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS2076149627 |
MUSK
|
Health Risk |
Likely pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS2076150607 |
CTNS
|
Health Risk |
Pathogenic |
Nephropathic cystinosis, Nephropathic cystinosis |
| RS2076151594 |
CTNS
|
Health Risk |
Likely pathogenic |
Ocular cystinosis, Juvenile nephropathic cystinosis |
| RS2076192966 |
MBOAT7
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2076195866 |
CTNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephropathic cystinosis, Ocular cystinosis |
| RS2076198741 |
CTNS
|
Health Risk |
Pathogenic |
Ocular cystinosis, Juvenile nephropathic cystinosis |
| RS2076198775 |
CTNS
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Ocular cystinosis |
| RS2076200436 |
CTNS
|
Health Risk |
Likely pathogenic |
Ocular cystinosis, Juvenile nephropathic cystinosis |
| RS2076205946 |
COLGALT1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2076207767 |
COLGALT1
|
Health Risk |
Likely pathogenic |
Brain small vessel disease 3, Brain small vessel disease 3 |
| RS2076245419 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Nephropathic cystinosis |
| RS2076253869 |
PSTPIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyogenic arthritis-pyoderma gangrenosum-acne syndrome, Pyogenic arthritis-pyoderma gangrenosum-acne syndrome |
| RS2076305143 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2076324884 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS2076326463 |
RAPSN
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 11, Fetal akinesia deformation sequence 1 |
| RS2076335306 |
RAPSN
|
Health Risk |
Pathogenic |
Hydrops fetalis, Hydrops fetalis |
| RS2076339915 |
MAPT
|
Health Risk |
Likely pathogenic |
— |
| RS2076368388 |
RAPSN
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 11 |
| RS2076368824 |
RAPSN
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 11, Fetal akinesia deformation sequence 1 |
| RS2076371827 |
PCDH15
|
Health Risk |
Likely pathogenic |
— |
| RS2076375159 |
RAPSN
|
Health Risk |
Conflicting classifications of pathogenicity |
Fetal akinesia deformation sequence 2, Fetal akinesia deformation sequence 2 |
| RS2076393894 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2076400400 |
GPC3
|
Health Risk |
Pathogenic |
Wilms tumor 1, GPC3-related disorder |
| RS2076400520 |
GPC3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Wilms tumor 1 |
| RS2076413 |
PLCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 12 |
| RS2076422949 |
RAPSN
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 11 |
| RS2076423585 |
RAPSN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 11, Fetal akinesia deformation sequence 1 |
| RS2076425196 |
LAMB3
|
Health Risk |
Likely pathogenic |
— |
| RS2076425356 |
RAPSN
|
Health Risk |
Likely pathogenic |
Fetal akinesia deformation sequence 2, Congenital myasthenic syndrome 11 |
| RS2076427827 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS2076431110 |
RAPSN
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 11 |
| RS2076432332 |
RAPSN
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 11 |
| RS2076433607 |
RAPSN
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 11 |
| RS2076434133 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2076434973 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2076453599 |
MBOAT7
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal recessive 57 |
| RS2076453977 |
MBOAT7
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2076486420 |
SYNE1
|
Health Risk |
Pathogenic |
Juvenile amyotrophic lateral sclerosis, Juvenile amyotrophic lateral sclerosis |
| RS2076489265 |
SPATA7
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS2076508722 |
MBOAT7
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 57 |
| RS2076520917 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset myopathy with fatal cardiomyopathy, Dilated cardiomyopathy 1G |